BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc. announced today that Dr. Lyndal Hesterberg, President and CEO, will be chairing the panel discussion as part of the Biologics and Drug Development Challenges section: “Novel Approaches to Protein Aggregation and Production” at the Biotechnology Industry Organization’s International Convention.
